{
    "id": "nkrqedpxvnmntfn2mufkgs3vy5uv7irw",
    "title": "Using physiology-based pharmacokinetic modelling for mechanistic analyses of drug action in disease and special populations",
    "info": {
        "author": [
            "Tobias Kanacher, Bayer Technology Services GmbH"
        ],
        "published": "July 21, 2014",
        "recorded": "May 2014",
        "category": [
            "Top->Medicine"
        ]
    },
    "url": "http://videolectures.net/mdo2014_kanacher_pharmacokinetic_modelling/",
    "segmentation": [
        [
            "Azaceta I'ma send it for last and and see is.",
            "Come on, let's say educational leave.",
            "I added a little something to to his talk and this will obviously has to do something with his situation with his new birds, but generally is, the talk will be about PBK based pharmacokinetic modeling and I would like to introduce this technique to you and how it is useful for mechanistic analyzers of drug action in disease and also in.",
            "Special populations.",
            "Um?"
        ],
        [
            "So the agenda will include a very short introduction or definition of PPK modeling.",
            "Then I will give you.",
            "Next three examples.",
            "In the first example will be PK modeling in preterms.",
            "Then I would like to show a PPK concept study for oncology, verbally simulated naked antibody, producing sounds a little tired, but it's it's totally.",
            "OK. And the thought example would be about model based risk assessment in Staten induced Mayo patties."
        ],
        [
            "Um, yeah, if you think about definition of PK modeling, it's always good to have a look at Vicky and what PK modeling is.",
            "It's a.",
            "It's a massive mathematical modeling technique which deals with.",
            "Human body it starts from the Union human body and tries to.",
            "And divided up and this central in his organs, which are represented as compartments in the model, and the organs are connected via mass transport, which is mathematically displayed and these.",
            "Representing the blood flow and also passive permeation.",
            "And with this model, the goal is to.",
            "Get concentration profiles not only in the blood but also in the each organs of your virtual individual which you have created with your PPK model and it's.",
            "Actually, the modeling is really orientated at clinical to clinical trials.",
            "And you can not only use medium human individuals, you can also.",
            "Um?",
            "Do it for special populations so you can create elderly people reflecting all the processes which are affected by age.",
            "You can also.",
            "Create obese or very tall individuals or you can go to even two children and the good thing about PK modeling is that.",
            "In contrast to classical pharmacokinetic modeling, which is purely purely data driven in the PPK model, you can kind of subtract the features of the compound from the features of the Physiology of the Physiology which is now lay down, lay down, out in the model and which can then be.",
            "Transfer to other populations and like the elderly and or the children, and even also to to other species.",
            "On yeah, besides the special Papa."
        ],
        [
            "Nations we have the very special populations and this brings me to my first example.",
            "The pre terms up to 93% of the pitambar neonatal intensive care units receive at least one unlicensed or.",
            "Off label use truck.",
            "So there is clearly.",
            "A high medical need for it.",
            "And this motivate."
        ],
        [
            "Us to create a new putem model and for that it was necessary to scale the model from and.",
            "Um and.",
            "And normal human to do a pre term in PK modeling the scaling of models to children and term bond.",
            "Neo Nate is quite established.",
            "Anne.",
            "However, there's a pity on Borneo needs differ.",
            "Very much from the charm bones and.",
            "The developer developmental changes are very rapid in preterms and they are strongly that they strongly impact the PK.",
            "The pharmacokinetics of drugs and the motivation of certain clearances are also triggered by birds like for example for CYP, 3A, four or two billion situation situation."
        ],
        [
            "So.",
            "In contrast to the normal term Borneo native pewter unborn infants show no loss of fat and water during the first days of life is known, and you see it here on this chart where the post Natal H is displaced.",
            "Why are the body weight the normal born child has a kind of a dip where it loses fat and water in the first days after birth, and then it grows again and this is not the case for preterms because they really have nothing left to lose.",
            "After birth, or the preterm birth.",
            "So the Peter model incorporates many physiological changes, like the post Natal grow, which is different to term bonds.",
            "The organ weights are different.",
            "The blood flow is different and also renal function and the hepatic function has to be adapted."
        ],
        [
            "Um, after birth pewter unborn children really show a kind of catch up, grow in the first 2 years and this is shown here.",
            "Here's the body weight against the post Natal Age and the grey.",
            "Area is there with other reprezentative.",
            "Body weight curves for normal bond children.",
            "They start considerably higher and the lines are now the growth curves for the put in bonds and they are adjusted in the model in a way that they catch up after two years."
        ],
        [
            "Also, there's the organ grow in the Twitter model is explicitly modeled and in permit, oversized for each of the available organs, from hard to muscle, and we had many different data sources.",
            "For the permutation of the model, you have to check it for consistency.",
            "And we are tried to only to use data for which over continuous time range given like from 24 to 14.",
            "We try to include as much in vivo imaging data as possible because it's not so nice if you read this paper about cadaver data.",
            "And they are also not not really reliable.",
            "And also we included the further differentiation of the GI tract, but this will be not shown today."
        ],
        [
            "So for evaluation of the Peter model we used.",
            "Data for nicotine administration and continuous, an antibiotic which is often given for tweet parents to prevent infection, and we started with a model for the grown humans of an adult human which was described.",
            "Early on and we just took the drug related parameters as defined for the adult model.",
            "Adapted the age dependent parameters from our future model to reflect the anatomy and Physiology of poo terms and also included the developmental changes in the clearance and for me.",
            "Kathleen it's mostly glomerulus filtration, which is primarily responsible and then we did peak based population simulations for 500 male and female subjects.",
            "Per guest SNL age group.",
            "And simulated this for two to three weeks intervals and got our results from there."
        ],
        [
            "And here you see the results, and this shown is a plasma concentration in the concession H group overtime.",
            "And after intravenous dosing and Gray area, and now the population simulation from our future model shown is here.",
            "The 95 two.",
            "5% percentile and the excess are the clinical data which we had from a publication.",
            "And you can really see that the clinical data is really, really nicely catch it by our model.",
            "Except maybe for this one.",
            "But this has a reason and this is a.",
            "Oldest Extension age group.",
            "And here the outliers have shown significantly higher serum creatinine level which is a measure to loss of renal function as these children were really ill and so it's not surprising that.",
            "The renal function goes down and actually this is not reflected by the future model.",
            "So for this to reflect the pre term model has to be adapted and this could be done if we.",
            "If you would include the individual winner clearance."
        ],
        [
            "We also did second data that for Power Center mall and we wanted to elevate evaluate if the liver metabolism is really catched in the pre term model is really represented correctly.",
            "And for that we also had an adult PPK model which we could use.",
            "And again we took the drug related parameters as defined in the adult body model.",
            "Then we adjusted the age dependent parameters for the few terms and especially focus was late on the changes in the tip and Zoltan Agatti in signs in the liver.",
            "Again we did population simulation versus PPK model.",
            "And he added that."
        ],
        [
            "That is shown is prediction versus observed for payment.",
            "I'm for Postmenstrual age and also for the post Natal age groups.",
            "And you can see there is a good match of the simulated with the predicted data.",
            "And therefore I hope you agree that PPK model for T perms can really support those finding in clinics and help to make this off label drug use safer."
        ],
        [
            "So the next example is from oncology.",
            "I'm."
        ],
        [
            "It's a big one is set.",
            "We had data from a concept study from Genentech, published literature which claims that naked antibody treatment can reduce off target effects and potentially extends ater product window and cancer treatment.",
            "And the objective for us far too to use an established PK PD model structure to investigate if.",
            "So literature data can be described and our approach.",
            "What's like that?",
            "We have a couple of pubic a model for the antibody, drug conjugate and also the antibody alone and also the toxic for alone so that we could describe the PK data in plus mom.",
            "Then we exploited the effect of the antibody treatment treatments which is sought to.",
            "Lower down the tissue upload and then we use the model to validate the activity of the naked antibody treatment in PK PD model."
        ],
        [
            "So this graph shows you the PK for the naked for the ADC, so the antibody drug conjugate is different doses and it really catches very nice the target mediated disposition like behavior of antibody concentrations.",
            "And this is also really done for all this Windows, so from that we think that the PK is really described well with our PK model."
        ],
        [
            "We went further to look that we can describe the.",
            "Antibody drug conjugate upload.",
            "After the Pew treatment is, it's sort that the naked antibody somehow separated the.",
            "Issues and as can be shown here, the tumor upload is.",
            "We use it very much in the tumor and also in the large and small intestine, and the simulations shown here are really in good agreement with observations.",
            "And also the."
        ],
        [
            "It became model can describe the plasma concentrations of the antibody drug conjugate with and without pre tossing, and this even in therapeutically relevant dozing machines."
        ],
        [
            "So that.",
            "We really can.",
            "Simulate the two micro in an in vivo model which is inhibited by the antibody drug conjugate with and without producing and the model.",
            "And also the in vivo data shows that difference between the.",
            "Free dosing and normal dosing.",
            "It's not really there, so the animals really show not a big different 4.",
            "Toast versus Pitt OST experience and also simulations are really extreme.",
            "They're really overlaying.",
            "So this example shows that the model structure can describe the in vivo data correctly and can also support the development of oncology drugs."
        ],
        [
            "And the last example shows how model based risk assessment of Staten can investigate it.",
            "We know that statins can induce new parties and this can be."
        ],
        [
            "Also investigated with PPK models, this is done.",
            "Why are an established recently established workflow where we have the PPK model?",
            "Which is coupled with toxic or dynamic marker.",
            "Which includes also in vitro toxicity data.",
            "And with the PPK simulation, we can calculate the toxicol dynamic marker and from there we can evaluate safety with.",
            "Not only for those those extrapolation, but also for drug track extrapolation, so we can do it for other settings and also for patients groups."
        ],
        [
            "Statins.",
            "It's a very successful drug family and it's known for a long time that it can induce myopathy.",
            "And this is linked to again function.",
            "It is known that Settings update update in the liver by OTP channels.",
            "And.",
            "Angie Jamik survey also found out that there are different Geno types of the transporter function and the genotypes show different plasma levels of statins like the normal transporter.",
            "Geno types show low plasma levels and the highest plasma levels are shown by the mutant genotypes and intermediate one shows the levels in the middle.",
            "However, mechanised IK explanation for this behavior is a bit lacking."
        ],
        [
            "And so we started this our PK model and tried to describe the data for the Geno type for two compounds.",
            "Here shown, simvastatin and provest at team and we started with simulation of the TT Geno type which was.",
            "Correctly catched or which was fitted to the to the data and also for the TC Geno type and the only difference in the model is set.",
            "The transporter function is knocked out so you can.",
            "You can just reduce activity of the transporter and this is the only change in the model and and this really gives a good description of the clinical data and it's a hint that Porter function is really linked to this.",
            "So is this Geno type?",
            "And.",
            "The intermediate.",
            "Geno type is simply created.",
            "By using the medium transporter activity from the TT and CC genotypes.",
            "So it's really in the middle.",
            "And there's also describes the data very well, and this is a strong hint that we really catch the.",
            "Mechanistic process behind."
        ],
        [
            "We did population simulations with thousand individuals for the three Geno types.",
            "And also compared to two clinical data and you see here that the population simulations from the PPK model really catches the in vivo data very well for the genotypes."
        ],
        [
            "An to.",
            "Getting out with the toxicology marker.",
            "I said it 2 forms in the beginning that you can really model organ concentrations in the PPK model and.",
            "This was done also especially for the muscle muscle and we choose and the C Max in the muscle from the PPK model and made a ratio of the IC 50 from an relevant toxicity essay.",
            "And that was used as an in vivo marker for the stadden toxicity."
        ],
        [
            "And if we now compare our population simulations, we see that they can really describe the toxico dynamic marker for the different genotypes and on the left side is shown for the medium model.",
            "And on the right side it is shown for the population simulations and you see here now cumulative distributions of the respective markers for the three genotypes and.",
            "It is visible is that that Oxy code dynamic marker is considerably higher for Zumba 13.",
            "Compared to poverty in which is also seen in the clinics and set the city, Geno type group has always the hyest toxic genetic marker incident rate.",
            "And how can we now?"
        ],
        [
            "Predict from this incident rates to clinical.",
            "Situation this is shown here where we have the.",
            "Predicted incident rate cumulative shown on the left side on the on the Y axis and we have also clinical incidence rates on the wide side from the search study.",
            "And this is a compared to the toxico dynamic marker.",
            "And.",
            "Time to come.",
            "Is and the window.",
            "Um and then calibrate our window for the toxicol.",
            "Kinetic incidents?",
            "To the data we find in clinics, you have to look at the Gray bar and the Gray bar is shifted.",
            "Or is it set in this?",
            "In this graph, innovas that it's really represents the incidence rate found in the clinics.",
            "Which is has a certain value for the TCG, new type.",
            "And for the TT genotype, we don't see significant incident rate.",
            "And from this calibration we can now predict the cystic incidence rate on from the green line, and this is really.",
            "Which is represented by the vertical bar, and this is really in good agreement with results found in the search study.",
            "And then.",
            "From that I really can.",
            "Save that the PPK concept which we developed here is very useful to estimate the risk not only for these two settings shown here, but also for other statins."
        ],
        [
            "And from that I hope that you believe that PK models enable mechanistic investigations of drugs a term very high level of detail even in special populations like Putin born you Nate.",
            "And that is methods presented here.",
            "Can um allow mechanistic investigations of not only of drug kinetics, but also an efficiency and on toxicity, and that this approaches have significant impact on development and with benefits.",
            "Estimations in drug discovery.",
            "And he said, I thank you."
        ],
        [
            "For your attention, and I'm happy to hear some questions.",
            "Houston, I had a question.",
            "You know you talked about preterm units that we commonly use unapproved.",
            "Can you elaborate on that a bit?",
            "That you use off label drugs or unapproved drugs for preterm babies.",
            "Besides America, teen or positive mall.",
            "Or I'm not sure if I get your question why or what kind of drugs do you give for pre term babies?",
            "There's no need of approval.",
            "I didn't understand you said something unapproved drugs an also off label drugs for pre term special population.",
            "Yeah operate on that.",
            "Yeah, that's a very good question.",
            "Normally one would not assume two to take.",
            "Unlabeled track for three pre terms.",
            "But however there is a medical need and for pre term says.",
            "Yeah, it it can be quite high and and.",
            "Normally no drug is.",
            "Approved for use in PU terms as they have no clinical studies in in are normally you don't have a clinical study in pre term so you have no other chance.",
            "And and in that way I think the this PBK model could improve that situations that we can do in silico clinical studies.",
            "And maybe skip a real clinical trial, which would not normally be necessary for the regulatory agencies.",
            "OK, OK with that, yeah.",
            "Perfect in time."
        ]
    ],
    "summarization": {
        "clip_0": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Azaceta I'ma send it for last and and see is.",
                    "label": 0
                },
                {
                    "sent": "Come on, let's say educational leave.",
                    "label": 0
                },
                {
                    "sent": "I added a little something to to his talk and this will obviously has to do something with his situation with his new birds, but generally is, the talk will be about PBK based pharmacokinetic modeling and I would like to introduce this technique to you and how it is useful for mechanistic analyzers of drug action in disease and also in.",
                    "label": 1
                },
                {
                    "sent": "Special populations.",
                    "label": 0
                },
                {
                    "sent": "Um?",
                    "label": 0
                }
            ]
        },
        "clip_1": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So the agenda will include a very short introduction or definition of PPK modeling.",
                    "label": 1
                },
                {
                    "sent": "Then I will give you.",
                    "label": 0
                },
                {
                    "sent": "Next three examples.",
                    "label": 1
                },
                {
                    "sent": "In the first example will be PK modeling in preterms.",
                    "label": 1
                },
                {
                    "sent": "Then I would like to show a PPK concept study for oncology, verbally simulated naked antibody, producing sounds a little tired, but it's it's totally.",
                    "label": 1
                },
                {
                    "sent": "OK. And the thought example would be about model based risk assessment in Staten induced Mayo patties.",
                    "label": 0
                }
            ]
        },
        "clip_2": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Um, yeah, if you think about definition of PK modeling, it's always good to have a look at Vicky and what PK modeling is.",
                    "label": 1
                },
                {
                    "sent": "It's a.",
                    "label": 0
                },
                {
                    "sent": "It's a massive mathematical modeling technique which deals with.",
                    "label": 1
                },
                {
                    "sent": "Human body it starts from the Union human body and tries to.",
                    "label": 0
                },
                {
                    "sent": "And divided up and this central in his organs, which are represented as compartments in the model, and the organs are connected via mass transport, which is mathematically displayed and these.",
                    "label": 0
                },
                {
                    "sent": "Representing the blood flow and also passive permeation.",
                    "label": 0
                },
                {
                    "sent": "And with this model, the goal is to.",
                    "label": 0
                },
                {
                    "sent": "Get concentration profiles not only in the blood but also in the each organs of your virtual individual which you have created with your PPK model and it's.",
                    "label": 0
                },
                {
                    "sent": "Actually, the modeling is really orientated at clinical to clinical trials.",
                    "label": 0
                },
                {
                    "sent": "And you can not only use medium human individuals, you can also.",
                    "label": 0
                },
                {
                    "sent": "Um?",
                    "label": 0
                },
                {
                    "sent": "Do it for special populations so you can create elderly people reflecting all the processes which are affected by age.",
                    "label": 0
                },
                {
                    "sent": "You can also.",
                    "label": 0
                },
                {
                    "sent": "Create obese or very tall individuals or you can go to even two children and the good thing about PK modeling is that.",
                    "label": 0
                },
                {
                    "sent": "In contrast to classical pharmacokinetic modeling, which is purely purely data driven in the PPK model, you can kind of subtract the features of the compound from the features of the Physiology of the Physiology which is now lay down, lay down, out in the model and which can then be.",
                    "label": 0
                },
                {
                    "sent": "Transfer to other populations and like the elderly and or the children, and even also to to other species.",
                    "label": 0
                },
                {
                    "sent": "On yeah, besides the special Papa.",
                    "label": 0
                }
            ]
        },
        "clip_3": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Nations we have the very special populations and this brings me to my first example.",
                    "label": 1
                },
                {
                    "sent": "The pre terms up to 93% of the pitambar neonatal intensive care units receive at least one unlicensed or.",
                    "label": 1
                },
                {
                    "sent": "Off label use truck.",
                    "label": 0
                },
                {
                    "sent": "So there is clearly.",
                    "label": 0
                },
                {
                    "sent": "A high medical need for it.",
                    "label": 0
                },
                {
                    "sent": "And this motivate.",
                    "label": 0
                }
            ]
        },
        "clip_4": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Us to create a new putem model and for that it was necessary to scale the model from and.",
                    "label": 0
                },
                {
                    "sent": "Um and.",
                    "label": 0
                },
                {
                    "sent": "And normal human to do a pre term in PK modeling the scaling of models to children and term bond.",
                    "label": 1
                },
                {
                    "sent": "Neo Nate is quite established.",
                    "label": 0
                },
                {
                    "sent": "Anne.",
                    "label": 0
                },
                {
                    "sent": "However, there's a pity on Borneo needs differ.",
                    "label": 0
                },
                {
                    "sent": "Very much from the charm bones and.",
                    "label": 1
                },
                {
                    "sent": "The developer developmental changes are very rapid in preterms and they are strongly that they strongly impact the PK.",
                    "label": 0
                },
                {
                    "sent": "The pharmacokinetics of drugs and the motivation of certain clearances are also triggered by birds like for example for CYP, 3A, four or two billion situation situation.",
                    "label": 0
                }
            ]
        },
        "clip_5": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So.",
                    "label": 0
                },
                {
                    "sent": "In contrast to the normal term Borneo native pewter unborn infants show no loss of fat and water during the first days of life is known, and you see it here on this chart where the post Natal H is displaced.",
                    "label": 1
                },
                {
                    "sent": "Why are the body weight the normal born child has a kind of a dip where it loses fat and water in the first days after birth, and then it grows again and this is not the case for preterms because they really have nothing left to lose.",
                    "label": 0
                },
                {
                    "sent": "After birth, or the preterm birth.",
                    "label": 1
                },
                {
                    "sent": "So the Peter model incorporates many physiological changes, like the post Natal grow, which is different to term bonds.",
                    "label": 0
                },
                {
                    "sent": "The organ weights are different.",
                    "label": 0
                },
                {
                    "sent": "The blood flow is different and also renal function and the hepatic function has to be adapted.",
                    "label": 0
                }
            ]
        },
        "clip_6": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Um, after birth pewter unborn children really show a kind of catch up, grow in the first 2 years and this is shown here.",
                    "label": 1
                },
                {
                    "sent": "Here's the body weight against the post Natal Age and the grey.",
                    "label": 0
                },
                {
                    "sent": "Area is there with other reprezentative.",
                    "label": 0
                },
                {
                    "sent": "Body weight curves for normal bond children.",
                    "label": 0
                },
                {
                    "sent": "They start considerably higher and the lines are now the growth curves for the put in bonds and they are adjusted in the model in a way that they catch up after two years.",
                    "label": 0
                }
            ]
        },
        "clip_7": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Also, there's the organ grow in the Twitter model is explicitly modeled and in permit, oversized for each of the available organs, from hard to muscle, and we had many different data sources.",
                    "label": 0
                },
                {
                    "sent": "For the permutation of the model, you have to check it for consistency.",
                    "label": 0
                },
                {
                    "sent": "And we are tried to only to use data for which over continuous time range given like from 24 to 14.",
                    "label": 0
                },
                {
                    "sent": "We try to include as much in vivo imaging data as possible because it's not so nice if you read this paper about cadaver data.",
                    "label": 1
                },
                {
                    "sent": "And they are also not not really reliable.",
                    "label": 1
                },
                {
                    "sent": "And also we included the further differentiation of the GI tract, but this will be not shown today.",
                    "label": 0
                }
            ]
        },
        "clip_8": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So for evaluation of the Peter model we used.",
                    "label": 1
                },
                {
                    "sent": "Data for nicotine administration and continuous, an antibiotic which is often given for tweet parents to prevent infection, and we started with a model for the grown humans of an adult human which was described.",
                    "label": 1
                },
                {
                    "sent": "Early on and we just took the drug related parameters as defined for the adult model.",
                    "label": 0
                },
                {
                    "sent": "Adapted the age dependent parameters from our future model to reflect the anatomy and Physiology of poo terms and also included the developmental changes in the clearance and for me.",
                    "label": 0
                },
                {
                    "sent": "Kathleen it's mostly glomerulus filtration, which is primarily responsible and then we did peak based population simulations for 500 male and female subjects.",
                    "label": 0
                },
                {
                    "sent": "Per guest SNL age group.",
                    "label": 0
                },
                {
                    "sent": "And simulated this for two to three weeks intervals and got our results from there.",
                    "label": 0
                }
            ]
        },
        "clip_9": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And here you see the results, and this shown is a plasma concentration in the concession H group overtime.",
                    "label": 0
                },
                {
                    "sent": "And after intravenous dosing and Gray area, and now the population simulation from our future model shown is here.",
                    "label": 0
                },
                {
                    "sent": "The 95 two.",
                    "label": 0
                },
                {
                    "sent": "5% percentile and the excess are the clinical data which we had from a publication.",
                    "label": 0
                },
                {
                    "sent": "And you can really see that the clinical data is really, really nicely catch it by our model.",
                    "label": 0
                },
                {
                    "sent": "Except maybe for this one.",
                    "label": 0
                },
                {
                    "sent": "But this has a reason and this is a.",
                    "label": 0
                },
                {
                    "sent": "Oldest Extension age group.",
                    "label": 0
                },
                {
                    "sent": "And here the outliers have shown significantly higher serum creatinine level which is a measure to loss of renal function as these children were really ill and so it's not surprising that.",
                    "label": 0
                },
                {
                    "sent": "The renal function goes down and actually this is not reflected by the future model.",
                    "label": 0
                },
                {
                    "sent": "So for this to reflect the pre term model has to be adapted and this could be done if we.",
                    "label": 0
                },
                {
                    "sent": "If you would include the individual winner clearance.",
                    "label": 0
                }
            ]
        },
        "clip_10": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "We also did second data that for Power Center mall and we wanted to elevate evaluate if the liver metabolism is really catched in the pre term model is really represented correctly.",
                    "label": 0
                },
                {
                    "sent": "And for that we also had an adult PPK model which we could use.",
                    "label": 0
                },
                {
                    "sent": "And again we took the drug related parameters as defined in the adult body model.",
                    "label": 1
                },
                {
                    "sent": "Then we adjusted the age dependent parameters for the few terms and especially focus was late on the changes in the tip and Zoltan Agatti in signs in the liver.",
                    "label": 1
                },
                {
                    "sent": "Again we did population simulation versus PPK model.",
                    "label": 0
                },
                {
                    "sent": "And he added that.",
                    "label": 0
                }
            ]
        },
        "clip_11": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "That is shown is prediction versus observed for payment.",
                    "label": 0
                },
                {
                    "sent": "I'm for Postmenstrual age and also for the post Natal age groups.",
                    "label": 0
                },
                {
                    "sent": "And you can see there is a good match of the simulated with the predicted data.",
                    "label": 0
                },
                {
                    "sent": "And therefore I hope you agree that PPK model for T perms can really support those finding in clinics and help to make this off label drug use safer.",
                    "label": 1
                }
            ]
        },
        "clip_12": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So the next example is from oncology.",
                    "label": 0
                },
                {
                    "sent": "I'm.",
                    "label": 0
                }
            ]
        },
        "clip_13": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "It's a big one is set.",
                    "label": 0
                },
                {
                    "sent": "We had data from a concept study from Genentech, published literature which claims that naked antibody treatment can reduce off target effects and potentially extends ater product window and cancer treatment.",
                    "label": 1
                },
                {
                    "sent": "And the objective for us far too to use an established PK PD model structure to investigate if.",
                    "label": 0
                },
                {
                    "sent": "So literature data can be described and our approach.",
                    "label": 0
                },
                {
                    "sent": "What's like that?",
                    "label": 0
                },
                {
                    "sent": "We have a couple of pubic a model for the antibody, drug conjugate and also the antibody alone and also the toxic for alone so that we could describe the PK data in plus mom.",
                    "label": 0
                },
                {
                    "sent": "Then we exploited the effect of the antibody treatment treatments which is sought to.",
                    "label": 1
                },
                {
                    "sent": "Lower down the tissue upload and then we use the model to validate the activity of the naked antibody treatment in PK PD model.",
                    "label": 0
                }
            ]
        },
        "clip_14": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So this graph shows you the PK for the naked for the ADC, so the antibody drug conjugate is different doses and it really catches very nice the target mediated disposition like behavior of antibody concentrations.",
                    "label": 0
                },
                {
                    "sent": "And this is also really done for all this Windows, so from that we think that the PK is really described well with our PK model.",
                    "label": 0
                }
            ]
        },
        "clip_15": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "We went further to look that we can describe the.",
                    "label": 1
                },
                {
                    "sent": "Antibody drug conjugate upload.",
                    "label": 0
                },
                {
                    "sent": "After the Pew treatment is, it's sort that the naked antibody somehow separated the.",
                    "label": 0
                },
                {
                    "sent": "Issues and as can be shown here, the tumor upload is.",
                    "label": 0
                },
                {
                    "sent": "We use it very much in the tumor and also in the large and small intestine, and the simulations shown here are really in good agreement with observations.",
                    "label": 1
                },
                {
                    "sent": "And also the.",
                    "label": 0
                }
            ]
        },
        "clip_16": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "It became model can describe the plasma concentrations of the antibody drug conjugate with and without pre tossing, and this even in therapeutically relevant dozing machines.",
                    "label": 0
                }
            ]
        },
        "clip_17": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So that.",
                    "label": 0
                },
                {
                    "sent": "We really can.",
                    "label": 0
                },
                {
                    "sent": "Simulate the two micro in an in vivo model which is inhibited by the antibody drug conjugate with and without producing and the model.",
                    "label": 0
                },
                {
                    "sent": "And also the in vivo data shows that difference between the.",
                    "label": 0
                },
                {
                    "sent": "Free dosing and normal dosing.",
                    "label": 0
                },
                {
                    "sent": "It's not really there, so the animals really show not a big different 4.",
                    "label": 0
                },
                {
                    "sent": "Toast versus Pitt OST experience and also simulations are really extreme.",
                    "label": 0
                },
                {
                    "sent": "They're really overlaying.",
                    "label": 0
                },
                {
                    "sent": "So this example shows that the model structure can describe the in vivo data correctly and can also support the development of oncology drugs.",
                    "label": 1
                }
            ]
        },
        "clip_18": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And the last example shows how model based risk assessment of Staten can investigate it.",
                    "label": 0
                },
                {
                    "sent": "We know that statins can induce new parties and this can be.",
                    "label": 0
                }
            ]
        },
        "clip_19": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Also investigated with PPK models, this is done.",
                    "label": 0
                },
                {
                    "sent": "Why are an established recently established workflow where we have the PPK model?",
                    "label": 0
                },
                {
                    "sent": "Which is coupled with toxic or dynamic marker.",
                    "label": 0
                },
                {
                    "sent": "Which includes also in vitro toxicity data.",
                    "label": 0
                },
                {
                    "sent": "And with the PPK simulation, we can calculate the toxicol dynamic marker and from there we can evaluate safety with.",
                    "label": 0
                },
                {
                    "sent": "Not only for those those extrapolation, but also for drug track extrapolation, so we can do it for other settings and also for patients groups.",
                    "label": 0
                }
            ]
        },
        "clip_20": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Statins.",
                    "label": 0
                },
                {
                    "sent": "It's a very successful drug family and it's known for a long time that it can induce myopathy.",
                    "label": 0
                },
                {
                    "sent": "And this is linked to again function.",
                    "label": 0
                },
                {
                    "sent": "It is known that Settings update update in the liver by OTP channels.",
                    "label": 0
                },
                {
                    "sent": "And.",
                    "label": 0
                },
                {
                    "sent": "Angie Jamik survey also found out that there are different Geno types of the transporter function and the genotypes show different plasma levels of statins like the normal transporter.",
                    "label": 0
                },
                {
                    "sent": "Geno types show low plasma levels and the highest plasma levels are shown by the mutant genotypes and intermediate one shows the levels in the middle.",
                    "label": 0
                },
                {
                    "sent": "However, mechanised IK explanation for this behavior is a bit lacking.",
                    "label": 0
                }
            ]
        },
        "clip_21": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And so we started this our PK model and tried to describe the data for the Geno type for two compounds.",
                    "label": 0
                },
                {
                    "sent": "Here shown, simvastatin and provest at team and we started with simulation of the TT Geno type which was.",
                    "label": 0
                },
                {
                    "sent": "Correctly catched or which was fitted to the to the data and also for the TC Geno type and the only difference in the model is set.",
                    "label": 0
                },
                {
                    "sent": "The transporter function is knocked out so you can.",
                    "label": 0
                },
                {
                    "sent": "You can just reduce activity of the transporter and this is the only change in the model and and this really gives a good description of the clinical data and it's a hint that Porter function is really linked to this.",
                    "label": 0
                },
                {
                    "sent": "So is this Geno type?",
                    "label": 0
                },
                {
                    "sent": "And.",
                    "label": 0
                },
                {
                    "sent": "The intermediate.",
                    "label": 0
                },
                {
                    "sent": "Geno type is simply created.",
                    "label": 0
                },
                {
                    "sent": "By using the medium transporter activity from the TT and CC genotypes.",
                    "label": 0
                },
                {
                    "sent": "So it's really in the middle.",
                    "label": 0
                },
                {
                    "sent": "And there's also describes the data very well, and this is a strong hint that we really catch the.",
                    "label": 0
                },
                {
                    "sent": "Mechanistic process behind.",
                    "label": 0
                }
            ]
        },
        "clip_22": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We did population simulations with thousand individuals for the three Geno types.",
                    "label": 0
                },
                {
                    "sent": "And also compared to two clinical data and you see here that the population simulations from the PPK model really catches the in vivo data very well for the genotypes.",
                    "label": 0
                }
            ]
        },
        "clip_23": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "An to.",
                    "label": 0
                },
                {
                    "sent": "Getting out with the toxicology marker.",
                    "label": 0
                },
                {
                    "sent": "I said it 2 forms in the beginning that you can really model organ concentrations in the PPK model and.",
                    "label": 0
                },
                {
                    "sent": "This was done also especially for the muscle muscle and we choose and the C Max in the muscle from the PPK model and made a ratio of the IC 50 from an relevant toxicity essay.",
                    "label": 0
                },
                {
                    "sent": "And that was used as an in vivo marker for the stadden toxicity.",
                    "label": 1
                }
            ]
        },
        "clip_24": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And if we now compare our population simulations, we see that they can really describe the toxico dynamic marker for the different genotypes and on the left side is shown for the medium model.",
                    "label": 0
                },
                {
                    "sent": "And on the right side it is shown for the population simulations and you see here now cumulative distributions of the respective markers for the three genotypes and.",
                    "label": 1
                },
                {
                    "sent": "It is visible is that that Oxy code dynamic marker is considerably higher for Zumba 13.",
                    "label": 1
                },
                {
                    "sent": "Compared to poverty in which is also seen in the clinics and set the city, Geno type group has always the hyest toxic genetic marker incident rate.",
                    "label": 0
                },
                {
                    "sent": "And how can we now?",
                    "label": 0
                }
            ]
        },
        "clip_25": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Predict from this incident rates to clinical.",
                    "label": 0
                },
                {
                    "sent": "Situation this is shown here where we have the.",
                    "label": 0
                },
                {
                    "sent": "Predicted incident rate cumulative shown on the left side on the on the Y axis and we have also clinical incidence rates on the wide side from the search study.",
                    "label": 1
                },
                {
                    "sent": "And this is a compared to the toxico dynamic marker.",
                    "label": 0
                },
                {
                    "sent": "And.",
                    "label": 0
                },
                {
                    "sent": "Time to come.",
                    "label": 0
                },
                {
                    "sent": "Is and the window.",
                    "label": 1
                },
                {
                    "sent": "Um and then calibrate our window for the toxicol.",
                    "label": 0
                },
                {
                    "sent": "Kinetic incidents?",
                    "label": 0
                },
                {
                    "sent": "To the data we find in clinics, you have to look at the Gray bar and the Gray bar is shifted.",
                    "label": 1
                },
                {
                    "sent": "Or is it set in this?",
                    "label": 0
                },
                {
                    "sent": "In this graph, innovas that it's really represents the incidence rate found in the clinics.",
                    "label": 0
                },
                {
                    "sent": "Which is has a certain value for the TCG, new type.",
                    "label": 0
                },
                {
                    "sent": "And for the TT genotype, we don't see significant incident rate.",
                    "label": 0
                },
                {
                    "sent": "And from this calibration we can now predict the cystic incidence rate on from the green line, and this is really.",
                    "label": 0
                },
                {
                    "sent": "Which is represented by the vertical bar, and this is really in good agreement with results found in the search study.",
                    "label": 0
                },
                {
                    "sent": "And then.",
                    "label": 0
                },
                {
                    "sent": "From that I really can.",
                    "label": 1
                },
                {
                    "sent": "Save that the PPK concept which we developed here is very useful to estimate the risk not only for these two settings shown here, but also for other statins.",
                    "label": 0
                }
            ]
        },
        "clip_26": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And from that I hope that you believe that PK models enable mechanistic investigations of drugs a term very high level of detail even in special populations like Putin born you Nate.",
                    "label": 1
                },
                {
                    "sent": "And that is methods presented here.",
                    "label": 1
                },
                {
                    "sent": "Can um allow mechanistic investigations of not only of drug kinetics, but also an efficiency and on toxicity, and that this approaches have significant impact on development and with benefits.",
                    "label": 0
                },
                {
                    "sent": "Estimations in drug discovery.",
                    "label": 0
                },
                {
                    "sent": "And he said, I thank you.",
                    "label": 0
                }
            ]
        },
        "clip_27": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "For your attention, and I'm happy to hear some questions.",
                    "label": 0
                },
                {
                    "sent": "Houston, I had a question.",
                    "label": 0
                },
                {
                    "sent": "You know you talked about preterm units that we commonly use unapproved.",
                    "label": 0
                },
                {
                    "sent": "Can you elaborate on that a bit?",
                    "label": 0
                },
                {
                    "sent": "That you use off label drugs or unapproved drugs for preterm babies.",
                    "label": 0
                },
                {
                    "sent": "Besides America, teen or positive mall.",
                    "label": 0
                },
                {
                    "sent": "Or I'm not sure if I get your question why or what kind of drugs do you give for pre term babies?",
                    "label": 0
                },
                {
                    "sent": "There's no need of approval.",
                    "label": 0
                },
                {
                    "sent": "I didn't understand you said something unapproved drugs an also off label drugs for pre term special population.",
                    "label": 0
                },
                {
                    "sent": "Yeah operate on that.",
                    "label": 0
                },
                {
                    "sent": "Yeah, that's a very good question.",
                    "label": 0
                },
                {
                    "sent": "Normally one would not assume two to take.",
                    "label": 0
                },
                {
                    "sent": "Unlabeled track for three pre terms.",
                    "label": 0
                },
                {
                    "sent": "But however there is a medical need and for pre term says.",
                    "label": 0
                },
                {
                    "sent": "Yeah, it it can be quite high and and.",
                    "label": 0
                },
                {
                    "sent": "Normally no drug is.",
                    "label": 0
                },
                {
                    "sent": "Approved for use in PU terms as they have no clinical studies in in are normally you don't have a clinical study in pre term so you have no other chance.",
                    "label": 0
                },
                {
                    "sent": "And and in that way I think the this PBK model could improve that situations that we can do in silico clinical studies.",
                    "label": 0
                },
                {
                    "sent": "And maybe skip a real clinical trial, which would not normally be necessary for the regulatory agencies.",
                    "label": 0
                },
                {
                    "sent": "OK, OK with that, yeah.",
                    "label": 0
                },
                {
                    "sent": "Perfect in time.",
                    "label": 0
                }
            ]
        }
    }
}